Statewide program seeks to address turnover in home and hospice industry
CARE Connect launched last week throughout the state after a pilot in 14 southeast Indiana counties, as well as in some agencies in Marion County.
CARE Connect launched last week throughout the state after a pilot in 14 southeast Indiana counties, as well as in some agencies in Marion County.
IU Health is joining forces with other anchor institutions on the northern edge of downtown—including The Children’s Museum, Ivy Tech Community College and Citizens Energy Group—to form what they are calling the Indy Health District.
Millions of people with private health insurance would be able to pick up over-the-counter methods like condoms, the “morning after” pill and birth control pills for free under a new proposal.
Baxter International, the largest manufacturer of IV fluids nationwide, is still only producing about 60% of its normal supply.
Progress House, about a mile east of downtown, serves about 300 people a year for substance use disorder.
Two new drugs—including one from Indianapolis-based Eli Lilly—and better detection methods offer promise for people dealing with the disease.
Ascension St. Vincent provided a sneak peak Monday of its Women and Infants Hospital, a $200 million project with 30 maternity suites and 109 neonatal intensive care unit rooms.
B. Braun Medical’s manufacturing site and distribution center in Daytona Beach were not seriously impacted by the hurricane, said a company spokesperson. The center produces about a quarter of the country’s IV fluids.
A lawsuit filed Tuesday by 20 states challenging a federal rule mandating higher staffing levels in nursing homes alleges that facilities will be forced to close.
The Indianapolis-based hospital system wants to add 34,645 square feet to its MD Anderson Cancer Center at 7979 Shadeland Ave., on the Community Hospital North campus.
The gift will fund operations at Gregory S. Fehribach Center at Eskenazi Health for the next five years and also create an endowment for future funding.
The jury deliberated for about three hours before returning a verdict in favor of Dr. Timothy Story, ending a lawsuit that lasted for about 3-1/2 years.
Growth has come chiefly from a series of mergers, including one earlier this year with Denver-based Everside Health.
Lilly has been making the case since August that its tirzepatide-based drugs are now “commercially available,” which the FDA agreed on. But the agency warned that patients and prescribers might still experience “localized supply disruptions.”
The new funding, for an advanced manufacturing and drug development center, will bring the Indianapolis-based drugmaker’s total investment in the Boone County site to more than $13 billion.
The the Swiss drugmaker will face off in the obesity area with leaders Novo Nordisk A/S and Indianapolis-based Eli Lilly and Co.
Elevance said it plans make its investment at two locations: its headquarters at 220 Virginia Avenue and another site at 4740 Victory Lane on the southeast side.
In contrast to Gov. Eric Holcomb, who largely stayed out of ongoing legislative negotiations, Braun firmly put his thumb on the scale in favor of one perspective over another across several contentious, ongoing discussions.
Recurrent shortages, shifting insurance coverage, indecision and a lack of guidance about side effects and dosing have led to challenges for some patients prescribed Mounjaro, Ozempic, Zepbound or Wegovy.
The Indianapolis-based drugmaker filed a suit in federal court this month, challenging the U.S. Food and Drug Administration’s ruling that the company’s experimental obesity treatment not a biological product.